Ak Biopharm Co Ltd, based in South Korea, is a pharmaceutical company.
One of their notable products is ICOSAPENT ETHYL, with a corresponding US DMF Number 36822.
Remarkably, this DMF maintains an Active status since its submission on June 07, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 25, 2022, and payment made on June 10, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II